Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Institut de Cancérologie de Lorraine clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our France and Switzerland registers with Institut de Cancérologie de Lorraine as lead sponsor. Synced 13 Nov 2026
9Current trials
4Recruiting now
0Drugs in these trials
2Trial registers
At a glance

Institut de Cancérologie de Lorraine is the lead sponsor of 9 current clinical trials in our France and Switzerland registers. 4 are recruiting patients now. All registered phases are Not applicable. The most-studied condition is Surgical Procedures.

ClinicalTrials.gov trials by status

  • Recruiting444%
  • Active, closed556%

Trials by phase

  • Not applicable9100%
01

Clinical trials sponsored by Institut de Cancérologie de Lorraine

9 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Spinal Palliation in Irradiation for Neoplastic Analgesia and Life Quality
NCT06884332 · ClinicalTrials.gov ↗ · Bone Metastasis, Oncology Pain
Not applicable Recruiting 2025-07 France
Guided Digital Self-Hypnosis Solution for Managing Hot Flashes in Patients Undergoing Adjuvant Hormone Therapy
NCT06552091 · ClinicalTrials.gov ↗ · Breast Cancer Female
Not applicable Recruiting 2024-12 France
Prognostic Value of Measuring CtDNA in a Cohort of Patients With Stage III and IV Upper Aero-digestive Tract (UADT) Cancer , Treated With Curative RADiOtherapy With or Without Concomitant Treatment.
NCT06479070 · ClinicalTrials.gov ↗ · SCC - Squamous Cell Carcinoma, Upper Aero-digestive Tract (UADT) Neoplasm
Not applicable Recruiting 2024-09 France, Switzerland
Efficacy of the MAEva Program (Meditation, Acceptance, and Commitment to Values) Among Patients Treated For Breast Cancer.
NCT07326800 · ClinicalTrials.gov ↗ · Non Metastatic Breast Cancer
Not applicable Recruiting 2026-02 France
Impact of Anesthesia Alarm Volume on Mental Workload in Surgical Trainees
NCT07089485 · ClinicalTrials.gov ↗ · Surgical Procedures, Noise, Hearing Disorder
Not applicable Active, closed 2026-03 France
Personalized Preventive Support for Cognitive Impairment in Non-Metastatic Breast Cancer (EFACog)
NCT05538000 · ClinicalTrials.gov ↗ · No Metastatic Breast Cancer
Not applicable Active, closed 2024-08 France
Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL)
NCT04866680 · ClinicalTrials.gov ↗ · Melanoma
Not applicable Active, closed 2023-01 France
Using Liquid Biopsy in Newly Diagnosed Patients With High Grade Adenocarcinoma of Ovarian Origin, Fallopian Tubes or Primary Peritoneal
NCT04511988 · ClinicalTrials.gov ↗ · Ovarian Cancer
Not applicable Active, closed 2021-07 France
Comparative Study of the Quality of Life of Patients Suffering From OTOTOXICITY Due to Chemotherapy Based on Platinum Salts Fitted With a Hearing Aid Compared to Those Not Fitted.
NCT05936034 · ClinicalTrials.gov ↗ · Cancer, Ototoxicity, Drug-Induced, Quality of Life
Not applicable Active, closed 2024-01 France

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Institut de Cancérologie de Lorraine trials

17 conditions
Surgical Procedures1Noise1Hearing Disorder1Mental Workload1Bone Metastasis1Oncology Pain1No Metastatic Breast Cancer1Breast Cancer Female1Melanoma1Non Metastatic Breast Cancer1Ovarian Cancer1Cancer1Ototoxicity, Drug-Induced1Quality of Life1Hearing Disorders1SCC - Squamous Cell Carcinoma1Upper Aero-digestive Tract (UADT) Neoplasm1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in France94
Clinical trials in Switzerland11

A trial with sites in more than one country appears in each of those registers.

04

Questions about Institut de Cancérologie de Lorraine trials

How many clinical trials does Institut de Cancérologie de Lorraine sponsor?

Institut de Cancérologie de Lorraine is the lead sponsor of 9 current trials on ClinicalTrials.gov in our France and Switzerland registers, as of the registry sync on 13 November 2026. Completed and withdrawn studies are not counted.

Are Institut de Cancérologie de Lorraine trials recruiting?

Yes. 4 of its 9 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 13 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.